Learn about Adoptive Cell Transfer Therapy with Tumor-Infiltrating Lymphocytes
BIOOCUS Biotech Ltd. presents a groundbreaking solution in the field of cancer treatment with its Adoptive Cell Transfer Therapy using Tumor-Infiltrating Lymphocytes (TIL). TIL therapy is a form of personalized immunotherapy that involves isolating and expanding a patient's own immune cells, specifically TILs, in a laboratory before reinfusing them back into the patient. This approach has shown promising results in targeting and destroying tumor cells, especially in advanced-stage cancers, Our TIL therapy offers a potential treatment option for patients who have exhausted other available therapies and have limited treatment options. By leveraging the natural ability of the immune system to recognize and attack cancer cells, TIL therapy represents a significant advancement in the fight against cancer
